Indonesia Compulsory License Move A Sharp Warning On Cost Pressures In Emerging Markets
This article was originally published in PharmAsia News
Indonesia decree for compulsory license of HIV/AIDS and hepatitis drugs shows prospect of further actions by some countries in Asia could gather speed.
You may also be interested in...
PERTH, Australia - A decree issued by Indonesia's health minister earlier this month requiring foreign drug manufacturers to build manufacturing plants in the country, or leave, would be disastrous to the industry, an industry leader said
Regulators in Southeast Asia are working to tighten bribery and corruption enforcement as part of a broader push ahead of an Association of Southeast Asian Nations trade pact in 2015 for greater transparency in pharmaceuticals.
The first commercial implant for St. Jude’s Allure Quadra in Hong Kong is a sign for optimism for its pacemaker business after last year’s disappointments in Japan.